Literature DB >> 25904831

The future of hepatitis C virus therapeutics.

Paul Y Kwo1.   

Abstract

Entities:  

Year:  2014        PMID： 25904831      PMCID： PMC4302491     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  3 in total

1.  Oral direct-acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus-related cirrhosis.

Authors:  Paul Y Kwo; A Joseph Tector
Journal:  Liver Transpl       Date:  2013-07       Impact factor: 5.799

Review 2.  New hepatitis C therapies: the toolbox, strategies, and challenges.

Authors:  Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2014-03-12       Impact factor: 22.682

Review 3.  Hepatitis C virus therapy in the direct acting antiviral era.

Authors:  Mitchell L Shiffman
Journal:  Curr Opin Gastroenterol       Date:  2014-05       Impact factor: 3.287
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.